Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Targeting danger molecules in tendinopathy: the HMGB1/TLR4 axis.

Akbar M, Gilchrist DS, Kitson SM, Nelis B, Crowe LAN, Garcia-Melchor E, Reilly JH, Kerr SC, Murrell GAC, McInnes IB, Millar NL.

RMD Open. 2017 Jul 28;3(2):e000456. doi: 10.1136/rmdopen-2017-000456. eCollection 2017.

2.

Mechanistic Modelling of Drug-Induced Liver Injury: Investigating the Role of Innate Immune Responses.

Shoda LK, Battista C, Siler SQ, Pisetsky DS, Watkins PB, Howell BA.

Gene Regul Syst Bio. 2017 May 30;11:1177625017696074. doi: 10.1177/1177625017696074. eCollection 2017.

3.

High mobility group box-1 contributes to anti-myeloperoxidase antibody-induced glomerular endothelial cell injury through a moesin-dependent route.

Deng H, Wang C, Chang DY, Hu N, Chen M, Zhao MH.

Arthritis Res Ther. 2017 Jun 6;19(1):125. doi: 10.1186/s13075-017-1339-4.

4.
5.

Single-molecule studies of high-mobility group B architectural DNA bending proteins.

Murugesapillai D, McCauley MJ, Maher LJ 3rd, Williams MC.

Biophys Rev. 2016 Nov 15;9(1):17-40. doi: 10.1007/s12551-016-0236-4. eCollection 2017 Feb. Review.

6.

From leukocyte recruitment to resolution of inflammation: the cardinal role of integrins.

Kourtzelis I, Mitroulis I, von Renesse J, Hajishengallis G, Chavakis T.

J Leukoc Biol. 2017 Sep;102(3):677-683. doi: 10.1189/jlb.3MR0117-024R. Epub 2017 Mar 14. Review.

PMID:
28292945
7.

HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Isorders (HAND).

Gougeon ML, Poirier-Beaudouin B, Durant J, Lebrun-Frenay C, Saïdi H, Seffer V, Ticchioni M, Chanalet S, Carsenti H, Harvey-Langton A, Laffon M, Cottalorda J, Pradier C, Dellamonica P, Vassallo M.

Heliyon. 2017 Feb 13;3(2):e00245. doi: 10.1016/j.heliyon.2017.e00245. eCollection 2017 Feb. Erratum in: Heliyon. 2017 Mar 16;3(3):e00259.

8.

Toll-like receptor signaling and stages of addiction.

Crews FT, Walter TJ, Coleman LG Jr, Vetreno RP.

Psychopharmacology (Berl). 2017 May;234(9-10):1483-1498. doi: 10.1007/s00213-017-4560-6. Epub 2017 Feb 17. Review.

9.

The role of neuroimmune signaling in alcoholism.

Crews FT, Lawrimore CJ, Walter TJ, Coleman LG Jr.

Neuropharmacology. 2017 Aug 1;122:56-73. doi: 10.1016/j.neuropharm.2017.01.031. Epub 2017 Feb 1. Review.

PMID:
28159648
10.

Microglial-derived miRNA let-7 and HMGB1 contribute to ethanol-induced neurotoxicity via TLR7.

Coleman LG Jr, Zou J, Crews FT.

J Neuroinflammation. 2017 Jan 25;14(1):22. doi: 10.1186/s12974-017-0799-4.

11.

Emerging role of HMGB1 in lung diseases: friend or foe.

Ding J, Cui X, Liu Q.

J Cell Mol Med. 2017 Jun;21(6):1046-1057. doi: 10.1111/jcmm.13048. Epub 2016 Dec 31. Review.

12.

Frontline Science: HMGB1 induces neutrophil dysfunction in experimental sepsis and in patients who survive septic shock.

Grégoire M, Tadié JM, Uhel F, Gacouin A, Piau C, Bone N, Le Tulzo Y, Abraham E, Tarte K, Zmijewski JW.

J Leukoc Biol. 2017 Jun;101(6):1281-1287. doi: 10.1189/jlb.5HI0316-128RR. Epub 2016 Dec 13.

13.

Molecular Pathogenesis of NASH.

Caligiuri A, Gentilini A, Marra F.

Int J Mol Sci. 2016 Sep 20;17(9). pii: E1575. Review.

14.

High Mobility Group Box Protein 1 Boosts Endothelial Albumin Transcytosis through the RAGE/Src/Caveolin-1 Pathway.

Shang D, Peng T, Gou S, Li Y, Wu H, Wang C, Yang Z.

Sci Rep. 2016 Aug 30;6:32180. doi: 10.1038/srep32180.

15.

Respiratory Syncytial Virus Infection Triggers Epithelial HMGB1 Release as a Damage-Associated Molecular Pattern Promoting a Monocytic Inflammatory Response.

Hosakote YM, Brasier AR, Casola A, Garofalo RP, Kurosky A.

J Virol. 2016 Oct 14;90(21):9618-9631. Print 2016 Nov 1.

16.

Stress and Withdrawal from Chronic Ethanol Induce Selective Changes in Neuroimmune mRNAs in Differing Brain Sites.

Knapp DJ, Harper KM, Whitman BA, Zimomra Z, Breese GR.

Brain Sci. 2016 Jul 27;6(3). pii: E25. doi: 10.3390/brainsci6030025.

17.

Emerging roles for HMGB1 protein in immunity, inflammation, and cancer.

Martinotti S, Patrone M, Ranzato E.

Immunotargets Ther. 2015 May 26;4:101-9. doi: 10.2147/ITT.S58064. eCollection 2015. Review.

18.

Tumour hypoxia promotes melanoma growth and metastasis via High Mobility Group Box-1 and M2-like macrophages.

Huber R, Meier B, Otsuka A, Fenini G, Satoh T, Gehrke S, Widmer D, Levesque MP, Mangana J, Kerl K, Gebhardt C, Fujii H, Nakashima C, Nonomura Y, Kabashima K, Dummer R, Contassot E, French LE.

Sci Rep. 2016 Jul 18;6:29914. doi: 10.1038/srep29914.

19.

Association between an elevated level of HMGB1 and non-small-cell lung cancer: a meta-analysis and literature review.

Xia Q, Xu J, Chen H, Gao Y, Gong F, Hu L, Yang L.

Onco Targets Ther. 2016 Jun 29;9:3917-23. doi: 10.2147/OTT.S104409. eCollection 2016.

20.

[Nle4, D-Phe7]-α-MSH Inhibits Toll-Like Receptor (TLR)2- and TLR4-Induced Microglial Activation and Promotes a M2-Like Phenotype.

Carniglia L, Ramírez D, Durand D, Saba J, Caruso C, Lasaga M.

PLoS One. 2016 Jun 30;11(6):e0158564. doi: 10.1371/journal.pone.0158564. eCollection 2016.

Supplemental Content

Support Center